Chemists make historic fluorine discovery

Chemists make historic fluorine discovery

9:07 AM, 11th September 2018
Chemistry Lab

TEXAS, US: A groundbreaking discovery by chemists at The University of Texas at San Antonio (UTSA) will have a significant impact on how pharmaceutical companies develop new drug treatments. The breakthrough involves fluorine, which forms the second strongest carbon bond (C-F) known to science, after the carbon-silicon (C-S) bond.

Fluorine is one of the most fundamental elements of life. In its fluoride form, it’s a mineral with anti-acid properties used in toothpaste and drinking water to prevent dental cavities. This small, non-toxic element is also widely used by medicinal chemists in cancer treatment, antibiotics, anti-depressants, steroids and other drugs. Fluorine is prevalent in modern drugs because it stabilizes drugs and improves their biological activity.

For many years, researchers in the UTSA Metalloprotein Research Laboratory, led by Aimin Liu, a Lutcher Brown Distinguished Professor, have been studying the regulation of thiols, compounds that affect a variety of biological functions in mammals such as redox stress levels, energy balance, cellular signalling, heart health, and autoimmune and neurological conditions. When thiol levels are stable, individuals are generally healthy. When they increase too much and for too long, conditions such as rheumatoid arthritis, breast cancer, Alzheimer's and Parkinson's diseases can develop.

Cysteine dioxygenase (CDO) and cysteamine dioxygenase (ADO) regulate the body’s thiol levels. When the thiol levels are elevated, CDO and ADO develop catalytic amplifiers to quickly remove thiol from the body. Scientists don’t yet know precisely how the enzymes make the amplifiers. The UTSA researchers were studying this when they made their significant discovery.

The scientists performed a technique on CDO called genetic code expansion. The cutting-edge technique was brought to UTSA by post-doctoral fellow Jiasong Li, and was initially invented by The Peter G. Schultz laboratory at The Scripps Research Institute.

The researchers created a new form of CDO with two very strong carbon-fluorine bonds. This should have made it more difficult for the enzyme to break those carbon-fluorine bonds and produce its catalytic amplifier. What they observed, however, surprised them. They discovered that the modified CDO was still able to break its carbon-fluorine bonds to generate its full catalytic assembly.

This is the first time that scientists have demonstrated the cleavage (breakage) of a carbon-fluorine bond through oxidation in proteins. This means that it may be possible that human bodies are capable of breaking these bonds in the drugs that are consumed.

The UTSA researchers also uncovered clues as to how thiols generate their catalytic amplifiers after the proteins are built. Their discovery is described in Nature Chemical Biology.

“This is an important discovery. More than 20 percent of pharmaceutical drugs contain fluorine. Because of their strength, fluorine-carbon bonds resist normal drug metabolism and can extend the beneficial lifetime of the drug in the body. Fluorine in drug molecules can also increase their ability to cross membrane barriers and enter cells. That the carbon-fluorine is strongly resistant to cleavage is a long-held belief in medicinal chemistry. Professor Liu's discovery changes that,” said Michael Doyle, the Rita and John Feik Distinguished University Chair in Medicinal Chemistry at UTSA.

To expand on their discovery, the Liu lab, including a third-year UTSA undergraduate student, graduate students, post-doctoral fellows and two staff chemists—Wendell Griffith and Daniel Wherritt—utilized a similar approach to determine the catalytic assembly of ADO, a sibling enzyme to CDO. In addition to successfully identifying the catalytic amplifier in ADO, they discovered a unique structural motif that hindered its detection by routine lab techniques. These findings are reported in another paper recently published in Angewandte Chemie, an internationally renowned chemical journal.

“Dr. Liu’s laboratory provides excellent opportunities for students to get involved in very interesting and impactful research projects,” said Waldemar Gorski, professor and chair of the UTSA Department of Chemistry.

While fluoride is widely used by medicinal chemists in drug treatments, Liu says his team’s discovery should remind pharmaceutical companies that fluorine chemistry is very complex. Although valuable, he recommends that they proceed with caution, because there is still much to learn.

“We see a rush by pharmaceutical companies to get drugs through development, into clinical trials and on the market,” said Liu. “This research reminds us that we need to be thorough and careful. Fluorine chemistry is very complex.”

“This research is vitally important,” said Howard Grimes, Interim Dean of the College of Sciences at UTSA. “Understanding the C-F bond is critical to our understanding of drug design and improving the lives of patients.” 

This research was supported by multiple grants from National Institute of General Medical Sciences, National Institute of Mental Health, National Science Foundation and Lutcher Brown Endowment Funds from The University of Texas at San Antonio.

© University of Texas at San Antonio

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


BASF to increase Hexanediol capacity at Ludwigshafen site

LUDWIGSHAFEN, GERMANY: BASF SE plans to increase the production capacity of 1,6-Hexanediol (HDO) at its Ludwigshafen Verbund site by more than 50 perc ...

Read more
Scientists pioneer a new way to turn sunlight into fuel

CAMBRIDGE, UK: The quest to find new ways to harness solar power has taken a step forward after researchers successfully split water into hydrogen and ...

Read more
Honeywell acquires gas processing technology developer

DES PLAINES, US: Honeywell has acquired Ortloff Engineers Ltd, a privately held licensor and industry-leading developer of specialized technologies th ...

Read more
AkzoNobel unveils 2019 colour of the year: Spiced Honey

AMSTERDAM, NETHERLANDS: AkzoNobel NV has unveiled Spiced Honey as the colour of the year for 2019. The shade was selected following expert research in ...

Read more
LyondellBasell, Covestro starts circular steam project in Maasvlakte

ROTTERDAM, NETHERLANDS: LyondellBasell (LYB) and its joint venture partner Covestro has started a large investment project at their site in Maasvlakte ...

Read more
BP installs plant operations advisor on Gulf of Mexico platforms

HOUSTON, US: BP Plc has successfully installed plant operations advisor (POA), a cloud-based advanced analytics solution developed with Baker Hughes, ...

Read more